Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status

Samantha L. Kendrick; Katalin Tus; George W. Wright; Elaine S. Jaffe; Andreas Rosenwald; Elı́as Campo; Wing Chung Chan; Joseph M. Connors; Rita M. Braziel; German Ott; Jan Delabie; James R. Cook; Dennis D. Weisenburger; Timothy C. Greiner; Kai Fu; Louis M. Staudt; Randy D. Gascoyne; David W. Scott; Lisa M. Rimsza

doi:10.3109/10428194.2015.1072767

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

The discovery of two distinct gene expression profiles (GEP) with either a germinal center B-cell (GCB) or activated B-cell (ABC) cell-of-origin (COO) within diffuse large B-cell lymphoma (DLBCL) a...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kendrick et al. (2015) studied this question.

synapsesocial.com/papers/6ab631f40b7b638cd8ad6852 https://doi.org/10.3109/10428194.2015.1072767

View Full Paper

Ask AI

Bookmark

Share

Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status

Ask about this paper

Abstract

Discussion

Cite This Study

Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading